Entering the Saudi medical device market requires going through precise regulatory steps that ensure the devices comply with international and local standards and guarantee the safety of patients and users. Among the most important of these steps are registration through the MDMA system and obtaining a marketing authorization from the SFDA (Saudi Food and Drug Authority).
This process starts with determining the classification and risk level of the medical device, preparing the required file in full, and then meeting ongoing post-licensing requirements. The following article explains these three stages in detail, step by step, from classification to marketing.
Classification and Risks
The first stage in registering medical devices through the MDMA system is classification. This step is not merely procedural; it accurately defines the entire registration pathway. Medical devices are divided into categories based on their risk level: low-risk devices such as simple tools or supplies that do not require body intervention, and high-risk devices such as implants or life-support devices.
Low-risk devices can obtain authorization more quickly, as the application is reviewed and approved directly after paying the fee, with inspection conducted later. High-risk devices, however, require more comprehensive supporting files, including compliance with a certified quality management system such as ISO 13485:2016, and a field inspection before the device is allowed into the market.
This means that the classification step directly determines the volume of required documents, the degree of technical review, and the level of inspection carried out by the SFDA. Thus, classification is the cornerstone of the licensing and marketing journey.
File Requirements
After defining the category and risk level, the second stage begins: preparing a comprehensive file to register the device through the MDMA system. This file is the main gateway to obtaining medical device marketing authorization from the SFDA.
The file includes detailed information about the establishment, such as the account number granted by the authority, the commercial registration showing medical devices and products activity, and the municipal and civil defense licenses. It also requires listing the devices or products intended for import or marketing in Saudi Arabia, along with the addresses and details of the supplying factories.
In addition, the file must contain documents proving the establishment’s compliance with quality system requirements, such as documenting storage and transportation procedures according to the manufacturer’s recommendations, and undertaking responsibility for tracking medical devices in the market and recording sales operations to ensure continuous monitoring. It is also necessary to include undertakings to report any changes to the data within ten days of occurrence, such as changes in contact information or commercial registration.
All these documents are uploaded through the unified electronic system “GHAD” linked to MDMA. Application acceptance depends on completing all requirements correctly. Here lies the importance of accuracy in preparing the file, since any missing documents may cause significant delays or rejection by the authority.
Post-Licensing
Many companies believe that obtaining authorization is the final step, but in reality, the post-licensing stage is just as important as the previous ones. After issuing the medical device marketing authorization, the establishment assumes numerous responsibilities before the SFDA.
Among the most important obligations are: immediate reporting of any incidents or malfunctions related to the device, submitting periodic reports on the device’s market performance, and continuously updating establishment data in case of any change, such as modifications in the commercial registration or changing the manufacturer. Full compliance with applying and documenting the quality management system on a regular basis is also required to maintain license validity.
The issued license is renewed annually, and the renewal request must be submitted 60 days before the current license expires, along with paying the fee based on the establishment’s category (fees range from SAR 5,000 to SAR 25,000 depending on the size and activity of the establishment). Failure to comply with these requirements exposes the establishment to penalties that may include device withdrawal from the market or suspension of its activity.
Therefore, managing the post-licensing stage is an essential part of ensuring marketing continuity and building trust with patients and healthcare practitioners.
Through these three stages—classification and risks, file requirements, and post-licensing—it becomes clear that registration through MDMA and obtaining SFDA marketing authorization is an integrated process, not merely an administrative step. Each stage directly impacts the others, and any failure in execution may hinder the device’s entry into the Saudi market or cause the establishment’s activity to be suspended.
Success in this journey requires clarity in classification, precision in file preparation, and strict commitment to post-licensing obligations. Therefore, every investor or company wishing to market medical devices in Saudi Arabia should approach this process as a long-term strategic plan.
And if you are considering starting this step, you can save time and effort by relying on specialized experts to support you at every stage. For a successful launch, do not hesitate to book a device registration session that will help you understand licensing requirements and implement them with the highest efficiency.
